News
ABT
103.69
+0.69%
0.71
With Approval Looking Likely, How Fast Will Sales of Cancer-Screening Blood Tests Rise?
Barron‘s · 11h ago
Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy
Seeking Alpha · 12h ago
3 High-Yielding Dividend Stocks That Are No-Brainer Buys for Retirees and Risk-Averse Investors
The Motley Fool · 14h ago
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth
The Motley Fool · 1d ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
NASDAQ · 1d ago
Weekly Report: what happened at ABT last week (0914-0918)?
Weekly Report · 1d ago
3 Dividend Stocks to Buy and Hold for 10 Years
The Motley Fool · 4d ago
Daily Dividend Report: PCAR,ABT,TXN,MCD,CL
NASDAQ · 4d ago
Notable ETF Inflow Detected - IHI, ABT, ISRG, SYK
NASDAQ · 4d ago
10 large and mega-cap U.S. healthcare stocks with the weakest momentum grades
Seeking Alpha · 4d ago
The Dividend Kings Ranked By Quality Scores (September 2026)
Seeking Alpha · 4d ago
The Hidden Winners Inside SCHD - September 2026
Seeking Alpha · 4d ago
Trump administration is said to weigh allowing most pharma licensing deals with China
Seeking Alpha · 4d ago
Why Wall Street Is Becoming Even More Bullish About This Dividend King
The Motley Fool · 4d ago
Looming biosimilar void risks $189B in lost U.S. healthcare savings: report
Seeking Alpha · 5d ago
Abbott Laboratories declares $0.63 dividend
Seeking Alpha · 5d ago
Press Release: Abbott declares 411th consecutive quarterly dividend
Dow Jones · 5d ago
Abbott declares 411th consecutive quarterly dividend
PR Newswire · 5d ago
Boston Scientific downgraded at Citi on increasing competition, cyberattack fallout
Seeking Alpha · 5d ago
Edwards Lifesciences Corp. Stock Advances 4.1%, Outperforms Peers
Dow Jones · 6d ago
More
Webull provides a variety of real-time ABT stock news. You can receive the latest news about Abbott Labs through multiple platforms. This information may help you make smarter investment decisions.
About ABT
Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.